Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20181030041500N2
IRCT20181030041500N2
Completed
Phase 2

Beneficial effects of N-acetylcysteine on systemic lupus erythematosus disease activityand its associated complications

Tehran University of Medical Sciences0 sites80 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
80
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Age more than 16
  • •Having lupus
  • •History of using prednisone, azathioprine, mycophenolate mofetil
  • •Satisfaction with participation in the study

Exclusion Criteria

  • •Pregnant or lactating patients
  • •Having any disease at the same time
  • •History of chronic infections
  • •Bronchiectasis
  • •Infection in last month
  • •History of severe infections or frequent infections
  • •Patients with excessive use of antioxidants (daily and without Prescription) and acetaminophen
  • •Acute SLE flares threatening vital organs
  • •People in need of treatment with intravenous cyclophosphamide
  • •Patients who are candidates for biological drugs rituximab, abatacept

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
.Effect of N-acetylcysteeine on non-alcoholic fatty liver disease
IRCT20201220049772N1Kashan University of Medical Sciences74
Recruiting
Phase 3
Effect of N-acetylcysteine in moderate to severe traumatic brain injury
IRCT20230815059150N1Iran University of Medical Sciences60
Completed
Phase 3
Effect of N-acetylcysteine supplementation in treatment of methadone maintenance treatment patientsAddiction.Other psychoactive substance related disorders
IRCT20170420033551N10Kashan University of Medical Sciences60
Completed
Not Applicable
Effect of N - Acetylcysteine in the prevention of ototoxicity caused by vancomycin.Peritonitis.Peritonitis, unspecified
IRCT201202148032N2Research Assistance Of Tabriz University Of Medical Science60
Completed
Phase 3
Effects of N-acetylcysteine administration in treatment of women with gestational diabetes mellitusGestational diabetes mellitus.Unspecified diabetes mellitus in pregnancy, childbirth and the puerperiumO24.9
IRCT20170513033941N71Kashan University of Medical Sciences76